Medical dictionary

Medical terminology normalized via MeSH, ICD-11, SNOMED CT.

62,341 terms indexed

• C5867256,7-methylenedioxy-4-(2,4-dimethoxyphenyl)quinolin-2(1H)-oneMeSH

  structure in first source

• C5820006,8,5'6'-tetrahydroxy-3'-methylflavoneMeSH

  from marine gorgonian coral-associated fungus Penicillium sp.; structure in first source

• C5707586,8-dibromo-2-methylquinazolineMeSH

  structure in first source

• C5708566,8-difluoro-1-(2-fluoroethyl)-7-(2-methylaminoethylamino)-4-oxo-1,4-dihydroquinoline-3-carboxylic acidMeSH

  a photodegradation product of fleroxacin; structure in first source

• C5728136,8-dihydroxy-2-(2-(3'-hydroxy-4'-methoxyphenyl)ethyl)chromoneMeSH

  from Chinese eaglewood; structure in first source

• C5798346,8-dihydroxy-7-methyl-3-styryl-3,4-dihydroisocoumarinMeSH

  synthetic analog of typharin; structure in first source

• C5762806,8-dinitro-2,4-dihydro-1H-benzo(b)(1,2,4)triazolo(4,3-d)(1,4)oxazin-1-oneMeSH

  structure in first source

• C5680986,8-diphenylimidazo(1,2-alpha)pyrazineMeSH

  structure in first source

• C5820606-((1-methyl-2-(pyridin-3-yl)pyrrolidin-3-yl)methoxy)hexanoic acidMeSH
• C5789926-((1-naphthylmethyl)sulfanyl)-9H-purineMeSH

  structure in first source

• C5882626-((2-(2-fluoro-6-(trifluoromethyl)phenoxy)-2-methylpropyl)carbamoyl)pyridine-3-carboxylic acidMeSH

  a TRPM8 cation channel antagonist; structure in first source

• C5869056-((2-acetylphenyl)amino)quinazoline-5,8-dioneMeSH

  structure in first source

• C5870556-((3-(((3-fluorophenethyl)amino)methyl)phenoxy)methyl)-4-methylpyridin-2-amineMeSH

  structure in first source

• C5882636-((3-((4-(5-((2-hydroxy-2-(8-hydroxy-2-oxo-1,2-dihydroquinolin-5-yl)ethyl)amino)pent-1-yn-1-yl)phenyl)carbamoyl)phenyl)sulfonyl)-4-((3-methoxyphenyl)amino)-8-methylquinoline-3-carboxamideMeSH

  inhibits phosphodiesterase 4, a beta2-adrenoceptor agonist

• C5750866-((4-ethylphenyl)methyl)-3',4',5',6'-tetrahydro-6'-(hydroxymethyl)spiro(isobenzofuran-1(3H),2'-(2H)pyran)-3',4',5'-triolMeSH

  inhibits sodium-glucose cotransporter 2; structure in first source

• C5823946-((6-fluoro-3,4-dihydro-2H-1-benzopyran-4-yl))oxy-N-(piperidin-4-yl)pyrazin-2-amineMeSH

  structure in first source

• C5752626-((9-(2-nitro-1H-imidazol-1-yl)allyloxy)methyl)glucopyranoseMeSH

  a radiosensitizing agent; structure in first source

• C5862916-((alpha-D-galactopyranosyloxy)methyl)-3-pyridinolMeSH

  structure in first source

• C5778466-(1,1,4,4-tetramethyl-1,2,3,4-tetrahydro-1,4-disilanaphthalen-6-yl)-2-naphthoic acidMeSH

  a retinoic acid receptor-beta,gamma-selective synthetic retinoid; structure in first source

• C5718096-(1,2,6,7-tetraoxaspiro(7.11)nonadec-4-yl)hexan-1-olMeSH

  structure in first source

• C5705436-(1-(4-fluoro-2-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-5-yl)-2H-1,4-benzoxazin-3(4H)-oneMeSH

  structure in first source

• C5870056-(1-(4-fluorophenyl)methyl-1H-pyrrol-2-yl)-2,4-dioxo-5-hexenoic acidMeSH

  structure in first source

• C5881726-(1-(benzylamino)ethyl)-2,2-dimethyl-2H-chromen-7-olMeSH

  structure in first source

• C5858886-(2,4-dichlorophenoxy)methyl-2H-(1,2,4)triazino(2,3-c)quinazolin-3(4H)-oneMeSH

  structure in first source

• C5815736-(2,4-dichlorophenyl)-8-ethyl-2-(3-fluoro-4-(piperazin-1-yl)phenylamino)pyrido(2,3-d)pyrimidin-7(8H)-oneMeSH

  structure in first source

• C5679416-(2,4-dihydroxyl-5-methylphenyl)-6-oxohexanoic acidMeSH

  sorbicillin analog from saline lands-derived fungus, Trichoderma; structure in first source

• C5830936-(2-(1-(1-(3-ethyl-3-hydroxypentyloxy)ethyl)-7-methyldihydro-1H-inden-4(2H,5H,6H,7H,7alphaH)-ylidene)ethylidene)spiro(2.5)octane-4,8-diolMeSH

  a vitamin D receptor modulator; structure in first source

• C5828016-(2-(2-(dimethylamino)ethylamino)ethylamino)-2-octyl-1H-benzo(de)isoquinoline-1,3(2H)-dioneMeSH

  an amonafide analog; structure in first source

• C5830016-(2-(4-(2-dimethylaminoethoxy)phenyl)-5-pyridin-4-yl-3H-imidazol-4-yl)naphthalen-1-olMeSH

  structure in first source

• C5815476-(2-(4-fluorophenyl)-6-(hydroxymethyl)-4,5,6,7-tetrahydropyrazolo(1,5-a)pyrimidin-3-yl)-2-(2-methylphenyl)pyridazin-3(2H)-oneMeSH

  structure in first source

• C5725696-(2-(dimethylamino)vinyl)-1,3-dimethyluracilMeSH

  structure in first source

• C5870386-(2-aminopropyl)benzofuranMeSH

  do not confuse with 1-(2, 3-dihydro-1-benzofuran-6-yl)propan-2-amine, which is also known as 6-APB

• C5861976-(2-hydroxybenzylideneamino)-2H-chromen-2-oneMeSH

  structure in first source

• C5732856-(2-methyl-6-(trifluoromethyl)pyridin-4-yl)-5-phenyl-1,2,4-triazin-3-amineMeSH

  structure in first source

• C5827526-(2-phenylethyl)-2,4-dihydroxy benzoic acid-2-O-beta-D-glucopyranosideMeSH

  from the leaves of Litsea coreana; structure in first source

• C5700096-(2-pyridinyl)-5,6-dihydrobenzimidazo(1,2-c)quinazolineMeSH

  structure in first source

• C5762686-(3,4-dihydro-1H-isoquinolin-2-yl)-N-(6-methylpyridin-2-yl)nicotinamideMeSH

  has antineoplastic activity; structure in first source

• C5715126-(3,4-dimethoxyphenyl)-3-pyridin-2-yl-(1,2,4)triazolo(3,4-b)(1,3,4)thiadiazoleMeSH

  a cardiomyogenic agent; structure in first source

• C5820596-(3-(benzoyloxy)-8-methyl-8-azabicyclo(3.2.1)octane-2-carboxoamido)hexanoic acidMeSH
• C5758476-(3-(dimethylamino)propylamino)-9-methoxy-11H-indeno(1,2-c)quinolin-11-oneMeSH

  structure in first source

• C5862116-(3-(trifluoromethyl)benzyloxy)(1,2,4)triazolo(3,4-a)phthalazineMeSH

  structure in first source

• C5853526-(3-cyano-6-ethyl-5-fluoro-1-(pyrimidin-2-yl)-1H-indol-2-yl)-N-(1,1,1-trifluoropropan-2-yl)pyridine-3-sulfonamideMeSH

  targets hepatitis C virus NS4B protein; structure in first source

• C5715326-(3-cyclopentyl-2-(4-(trifluoromethyl)-1H-imidazol-1-yl)propanamido)nicotinic acidMeSH

  An hepatoselective glucokinase activator.

• C5730996-(3-fluoro-2-(hydroxymethyl)propyl)-1,5-dimethylpyrimidin-2,4(1H,3H)-dioneMeSH

  for imaging herpes simplex virus type 1 thymidine kinase expression; structure in first source

• C5771126-(3-fluoropropyl)-3-(2-(azepan-1-yl)ethyl)benzo(d)thiazol-2(3H)-oneMeSH

  a sigma-1 receptor ligand; structure in first source

• C5689026-(3-hydroxy-3-methylbutyl)-2'-(7-hydroxy-3,7-dimethyloct-3-enyl)-3',4',7-trimethoxyflavanoneMeSH

  structure in first source

• C5598386-(3-hydroxy-4-oxo-2-methyl-4(1H)-pyridin-1-yl)norleucineMeSH

  an iron chelating agent; structure in first source

• C5741036-(3-methyl-2-buten-1-yl)ophiogloninMeSH

  from the fern Ophioglossum pedunculosum; structure in first source

• C5722566-(4-(1-cyclobutyl-piperidin-4-yloxy)-phenyl)-4,4-dimethyl-4,5-dihydro-2H-pyridazin-3-oneMeSH

  structure in first source

• C5884066-(4-(1H-1,2,4-triazol-3-yl)phenyl)-1-(2-(tetrahydro-2H-pyran-4-yl)ethyl)-1H-imidazo(4,5-b)pyrazin-2(3H)-oneMeSH

  an mTOR kinase inhibitor; structure in first source